Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

There is an urgent need for an improved vaccine against tuberculosis. Heterologous prime-boost immunization regimes induce higher levels of cellular immunity than homologous boosting with the same vaccine. Using BCG as the priming immunization in such a regime allows for the retention of the benefic...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Mcshane, H, Pathan, A, Sander, C, Goonetilleke, N, Fletcher, H, Hill, A
פורמט: Journal article
שפה:English
יצא לאור: 2005